Citation: Fh. Schroder, Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects, BJU INT, 83(2), 1999, pp. 161-170
Citation: Bg. Blijenberg et al., On the standardization of total prostate-specific antigen: an exercise with two reference preparations, CLIN CH L M, 37(5), 1999, pp. 545-552
Authors:
van Brussel, JP
van Steenbrugge, GJ
Romijn, JC
Schroder, FH
Mickisch, GHJ
Citation: Jp. Van Brussel et al., Chemosensitivity of prostate cancer cell lines and expression of multidrugresistance-related proteins, EUR J CANC, 35(4), 1999, pp. 664-671
Authors:
Alexander, FE
Andriole, GL
Aus, G
Auvinen, A
Beensterboer, P
Blijenberg, BG
Bonardi, R
Buys, S
Candas, B
Ciatto, S
Crawford, ED
Demers, R
de Koning, HJ
Denis, L
Dijk, MA
Figueiredo, F
Gellman, EP
Gohagan, J
Hakama, M
Hugosson, J
Kirkels, WI
Kranse, R
van der Kwast, TH
Lilja, H
Maattanen, L
Mandel, J
Miller, AB
Monteiro, H
Nelen, V
Oberman, A
Paez, A
Prorok, PC
Reding, D
Rietbergen, JWBW
Rose, DB
Sanchez, AB
Schroder, FH
da Silva, EC
Simpson, N
Smith, PH
Stadaert, B
Stenman, UH
Teppo, L
Turkes, A
Weissfeld, JL
Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271
Authors:
Blom, JHM
van Poppel, H
Marechal, JM
Jacqmin, D
Sylvester, R
Schroder, FH
de Prijck, L
Citation: Jhm. Blom et al., Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC randomized phase III protocol 30881, EUR UROL, 36(6), 1999, pp. 570-575
Authors:
Verkoelen, CF
Kok, DJ
van der Boom, BG
de Jonge, HR
Schroder, FH
Romijn, JC
Citation: Cf. Verkoelen et al., LLC-PK1 cells as a model system to study proximal tubule transport of water and other compounds relevant for renal stone disease, UROL RES, 27(2), 1999, pp. 109-115
Authors:
de Water, R
Noordermeer, C
van der Kwast, TH
Nizze, H
Boeve, ER
Kok, DJ
Schroder, FH
Citation: R. De Water et al., Calcium oxalate nephrolithiasis: Effect of renal crystal deposition on thecellular composition of the renal interstitium, AM J KIDNEY, 33(4), 1999, pp. 761-771
Citation: R. Boer et Fh. Schroder, Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction, PROSTATE, 40(2), 1999, pp. 130-131
Authors:
Kranse, R
Beemsterboer, P
Rietbergen, J
Habbema, D
Hugosson, J
Schroder, FH
Citation: R. Kranse et al., Predictors for biopsy outcome in the European randomized study of screening for prostate cancer (Rotterdam region), PROSTATE, 39(4), 1999, pp. 316-322
Authors:
Verkoelen, CF
van der Boom, BG
Kok, DJ
Houtsmuller, AB
Visser, P
Schroder, FH
Romijn, JC
Citation: Cf. Verkoelen et al., Cell type-specific acquired protection from crystal adherence by renal tubule cells in culture, KIDNEY INT, 55(4), 1999, pp. 1426-1433
Authors:
Dubbink, HJ
Hoedemaeker, RF
van der Kwast, TH
Schroder, FH
Romijn, JC
Citation: Hj. Dubbink et al., Human prostate-specific transglutaminase: A new prostatic marker with a unique distribution pattern, LAB INV, 79(2), 1999, pp. 141-150
Citation: Jbw. Rietbergen et al., The changing pattern of prostate cancer at the time of diagnosis: Characteristics of screen detected prostate cancer in a population based screening study, J UROL, 161(4), 1999, pp. 1192-1198
Authors:
Beemsterboer, PMM
Kranse, R
de Koning, HJ
Habbema, JDF
Schroder, FH
Citation: Pmm. Beemsterboer et al., Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam), INT J CANC, 84(4), 1999, pp. 437-441
Authors:
Hoedemaeker, RF
Kranse, R
Rietbergen, JBW
Kruger, AEB
Schroder, FH
van der Kwast, TH
Citation: Rf. Hoedemaeker et al., Evaluation of prostate needle biopsies in a population-based screening study - The impact of borderline lesions, CANCER, 85(1), 1999, pp. 145-152
Authors:
Jongsma, J
Oomen, MH
Noordzij, MA
Van Weerden, WM
Martens, GJM
van der Kwast, TH
Schroder, FH
van Steenbrugge, GJ
Citation: J. Jongsma et al., Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model, AM J PATH, 154(2), 1999, pp. 543-551
Authors:
Schroder, FH
van der Maas, P
Beemsterboer, P
Kruger, AB
Hoedemaeker, R
Rietbergen, J
Kranse, R
Citation: Fh. Schroder et al., Evaluation of the digital rectal examination as a screening test for prostate cancer, J NAT CANC, 90(23), 1998, pp. 1817-1823